Biophysical characterisation of GlycoPEGylated recombinant human factor VIIa

International Journal of Pharmaceutics

Volumn 406, Issue 1-2, 2011, Pages 62-68

  Plesner, Bitten ^a,b   Westh, Peter ^a   Nielsen, Anders D ^b  

^a ROSKILDE UNIVERSITY   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Circular dichroism; Differential scanning calorimetry; GlycoPEGylation; Light scattering; rFVIIa; Stability

Indexed keywords

RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; BIOPHYSICS; CIRCULAR DICHROISM; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STABILITY; DRUG STRUCTURE; LIGHT SCATTERING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; THERMOSTABILITY;

BIOPHYSICAL PHENOMENA; CALORIMETRY, DIFFERENTIAL SCANNING; CIRCULAR DICHROISM; DRUG STABILITY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FACTOR VIIA; HUMANS; LIGHT; PROTEIN STABILITY; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SCATTERING, RADIATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 79951580612     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.12.034     Document Type: Article

References (32)

1. P. Bailon, A. Palleroni, C.A. Schaffer, C.L. Spence, W.J. Fung, J.E. Porter, G.K. Ehrlich, W. Pan, Z.X. Xu, M.W. Modi, A. Farid, and W. Berthold Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C Bioconjug. Chem. 12 2001 195 202 (Pubitemid 32235471)
2. V.A. Bloomfield Static and dynamic light scattering from aggregating particles Biopolymers 54 2000 168 172 (Pubitemid 30482316)
3. E.W. Davie, K. Fujikawa, and W. Kisiel The coagulation cascade - initiation, maintenance, and regulation Biochemistry 30 1991 10363 10370
4. C. Dhalluin, A. Ross, L.A. Leuthold, S. Foser, B. Gsell, F. Muller, and H. Senn Structural and biophysical characterization of the 40 kDa PEG-interferon-alpha(2a) and its individual positional isomers Bioconjug. Chem. 16 2005 504 517 (Pubitemid 40696041)
5. G. Digilio, L. Barbero, C. Bracco, D. Corpillo, P. Esposito, G. Piquet, S. Traversa, and S. Aime NMR structure of two novel polyethylene glycol conjugates of the human growth hormone-releasing factor, hGRF(1-29)-NH2 J. Am. Chem. Soc. 125 2003 3458 3470 (Pubitemid 36512420)
6. C.S. Fishburn The pharmacology of PEGylation: balancing PD with PK to generate novel therapeutics J. Pharm. Sci. 97 2008 4167 4183
7. J.M. Harris, and R.B. Chess Effect of pegylation on pharmaceuticals Nat. Rev. Drug Discov. 2 2003 214 221 (Pubitemid 37361666)
8. J.M. Harris, N.E. Martin, and M. Modi Pegylation - a novel process for modifying pharmacokinetics Clin. Pharmacokinet. 40 2001 539 551 (Pubitemid 32738660)
9. K.D. Hinds, and S.W. Kim Effects of PEG conjugation on insulin properties Adv. Drug Deliv. Rev. 54 2002 505 530 (Pubitemid 34615546)
10. S.M. Kelly, T.J. Jess, and N.C. Price How to study proteins by circular dichroism Biochim. Biophys. Acta Proteins Proteomics 1751 2005 119 139 (Pubitemid 41112231)
11. B.A. Konkle, L.S. Ebbesen, E. Erhardtsen, R.P. Bianco, T. Lissitchkov, L. Rusen, and M.A. Serban Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors J. Thromb. Haemost. 5 2007 1904 1913 (Pubitemid 47288949)
12. M. Kunitani, G. Dollinger, D. Johnson, and L. Kresin Online characterization of polyethylene glycol-modified proteins J. Chromatogr. 588 1991 125 137
13. M.M. Kurfurst Detection and molecular-weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl-sulfate polyacrylamide-gel electrophoresis Anal. Biochem. 200 1992 244 248
14. R. Lumry, and H. Eyring Conformation changes of proteins J. Phys. Chem. 58 1954 110 120
15. M.J. Manco-Johnson, T.C. Abshire, A.D. Shapiro, B. Riske, M.R. Hacker, R. Kilcoyne, J.D. Ingram, M.L. Manco-Johnson, S. Funk, L. Jacobson, L.A. Valentino, W.K. Hoots, G.R. Buchanan, D. DiMichele, M. Recht, D. Brown, C. Leissinger, S. Bleak, A. Cohen, P. Mathew, A. Matsunaga, D. Medeiros, D. Nugent, G.A. Thomas, A.A. Thompson, K. McRedmond, J.M. Soucie, H. Austin, and B.L. Evatt Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia N. Engl. J. Med. 357 2007 535 544 (Pubitemid 47236278)
16. S.A. Marshall, G.A. Lazar, A.J. Chirino, and J.R. Desjarlais Rational design and engineering of therapeutic proteins Drug Discov. Today 8 2003 212 221 (Pubitemid 36298676)
17. F. Meng, B.N. Manjula, P.K. Smith, and S.A. Acharya PEGylation of human serum albumin: reaction of PEG-phenyl-isothiocyanate with protein Bioconjug. Chem. 19 2008 1352 1360 (Pubitemid 352032333)
18. A.S. Morar, J.R.L. Schrimsher, and M.D. Chavez PEGylation of proteins: a structural approach Biopharm. Int. 19 2006 34 49
19. A.D. Nielsen, and C. Rischel Biophysical characterisation of GlycoPEGylated® recombinant human FVIIa XXII International Society on Thrombosis and Haemostasis (ISTH) 11-16 July 2009 Boston, MA, USA 2009 11-7-0010
20. O.W. Odom, W. Kudlicki, G. Kramer, and B. Hardesty An effect of polyethylene glycol 8000 on protein mobility in sodium dodecyl sulfate-polyacrylamide gel electrophoresis and a method for eliminating this effect Anal. Biochem. 245 1997 249 252 (Pubitemid 27082260)
21. L. Palm, M. Renau, T. Jepsen, S. Fexby, A.D. Nielsen, and S. Valentin Analysis and characterization of GlycoPEGylated® recombinant human FVIIa XXII International Society on Thrombosis and Haemostasis (ISTH) 11-16 July 2009 Boston, MA, USA 2009
22. G. Pasut, A. Guiotto, and F. Veronese Protein, peptide and non-peptide drug PEGylation for therapeutic application Expert Opin. Ther. Pat. 14 2004 859 894 (Pubitemid 38868068)
23. R.S. Rajan, T.S. Li, M. Aras, C. Sloey, W. Sutherland, H. Arai, R. Briddell, O. Kinstler, A.M.K. Lueras, Y. Zhang, H. Yeghnazar, M. Treuheit, and D.N. Brems Modulation of protein aggregation by polyethylene glycol conjugation: GCSF as a case study Protein Sci. 15 2006 1063 1075
24. P. Sen, S. Ghosh, M. Ezban, U.R. Pendurthi, and L.V.M. Rao Effect of glycoPEGylation on factor VIIa binding and internalization Haemophilia 16 2010 339 348
25. H.R. Stennicke, H. Ostergaard, R.J. Bayer, M.S. Kalo, K. Kinealy, P.K. Holm, B.B. Sorensen, D. Zopf, and S.E. Bjorn Generation and biochemical characterization of glycoPEGylated factor VIIa derivatives Thromb. Haemost. 100 2008 920 928
26. Y. Tong, K. Zhong, H. Tian, X.D. Gao, X.Y. Xu, X.J. Yin, and W.B. Yao Characterization of a monoPEG20000-endostar Int. J. Biol. Macromol. 46 2010 331 336
27. F.M. Veronese, and M. Morpurgo Bioconjugation in pharmaceutical chemistry Farmaco 54 1999 497 516 (Pubitemid 29414849)
28. F.M. Veronese, and G. Pasut PEGylation, successful approach to drug delivery Drug Discov. Today 10 2005 1451 1458 (Pubitemid 41483874)
29. F.M. Veronese, A. Mero, and G. Pasut Protein PEGylation, basic science and biological applications F.M. Veronese, PEGylated Protein Drugs: Basic Science and Clinical Applications 2009 Birkhauser Verlag Press Basel 11 31
30. P. Wildgoose, D. Foster, J. Schiodt, F.C. Wiberg, J.J. Birktoft, and L.C. Petersen Identification of a calcium-binding site in the protease domain of human blood-coagulation factor-VII - evidence for its role in factor-VII tissue factor interaction Biochemistry 32 1993 114 119 (Pubitemid 23033327)
31. S. Zalipsky Chemistry of polyethylene-glycol conjugates with biologically-active molecules Adv. Drug Deliv. Rev. 16 1995 157 182
32. S. Zalipsky, and J.M. Harris Chemistry and Biological Applications of PEG J.M. Harris, S. Zalipsky, Poly(ethylene glycol) Chemistry and Biological Application 1997 American Chemical Society Washington, DC 1 13